Changeflow GovPing Healthcare RACTHERA Trademark Published for Opposition
Routine Notice Added Final

RACTHERA Trademark Published for Opposition

Favicon for changeflow.com ChangeBridge: Trademarks - Medical Services (Class 044)
Published March 20th, 2026
Detected March 25th, 2026
Email

Summary

The USPTO has published the RACTHERA trademark application for opposition. The application covers a wide range of services related to scientific research, development, and testing, particularly in the fields of stem cells, gene therapy, and regenerative medicine, as well as pharmaceutical and biological preparations.

What changed

The United States Patent and Trademark Office (USPTO) has published the trademark application for 'RACTHERA' (TM79433668) for opposition. This publication signifies that the application has passed initial examination and is now open for any party to file an opposition within a specified period. The trademark covers a broad scope of goods and services, including stem cells for research, biological tissue cultures, cell culture media and reagents for scientific and research purposes, diagnostic reagents (excluding medical/veterinary use), and various chemical and biochemical preparations for scientific applications.

The abstract also details extensive services related to research and development in pharmaceuticals, regenerative medical products, stem cells, gene therapy, and medical technology. This includes conducting clinical trials, testing, inspection, and providing consultancy services in these areas. Additionally, the application covers IT services such as SaaS, PaaS, server hosting, electronic data storage, computer system design, software engineering, and data recovery. Companies involved in pharmaceutical research, biotechnology, and related scientific endeavors should be aware of this publication as it pertains to the intellectual property rights associated with the RACTHERA mark.

What to do next

  1. Monitor opposition period for RACTHERA trademark application TM79433668
  2. Assess potential conflicts with existing intellectual property

Source document (simplified)

← USPTO Trademark Applications

RACTHERA

Published for Opposition TM79433668 Kind: published Mar 20, 2026

Abstract

Stem cells for research purposes; stem cells for scientific purposes; stem cells, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; cell culture media for scientific and research purposes; cell culture reagents for scientific and research use; media for bacteriological cultures, other than for medical or veterinary purposes; reagents for bacteriological cultures, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; diagnostic reagents and preparations, except for medical or veterinary use; reagents for scientific purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemical preparations for scientific purposes; chemicals for use in the manufacture of pharmaceuticals; industrial chemicals; chemicals; biological preparations, other than for medical or veterinary purpose; Testing, inspection, research or development of pharmaceuticals; providing information, advice and consultancy services relating to testing, inspection, research or development of pharmaceuticals; testing, inspection, research or development of regenerative medical products; providing information, advice and consultancy services relating to testing, inspection, research or development of regenerative medical products; medical and scientific research, namely, conducting clinical trials for others; testing, inspection or research of stem cells; providing information, advice and consultancy services relating to testing, inspection or research of stem cells; testing, inspection or research of gene therapy; providing information, advice and consultancy services relating to testing, inspection or research of gene therapy; testing, inspection or research of medicine in the field of gene therapy; providing information, advice and consultancy services relating to testing, inspection or research of medicine in the field of gene therapy; testing, inspection or research of regenerative medicine; providing information, advice and consultancy services relating to testing, inspection or research of regenerative medicine; testing, inspection or research of medical and medical technology; providing information, advice and consultancy services relating to testing, inspection or research of medical and medical technology; testing, inspection or research of chemicals; testing, inspection or research of biology; research and development of pharmaceuticals and regenerative medical products for others; research and development of new products for others; scientific research; scientific laboratory services; testing, inspection, research or development of medical apparatus and instruments; providing information, advice and consultancy services relating to testing, inspection, research or development of medical apparatus and instruments; testing, inspection or research on functionality of machines, apparatus and instruments; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing information, advice and consultancy services relating to testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; software as a service (SaaS); platform as a service (PaaS); server hosting; electronic data storage; providing temporary use of non-downloadable computer programs on data networks; computer system design; development of computer platforms; software engineering services for data processing; computer programming services; computer software design, computer programming, and maintenance of computer software; off-site data backup; recovery of computer data; computer security consultancy; telecommunication network security consultancy; information technology (IT) support services, namely troubleshooting of computer software problems; Electroencephalographs; pulse meters; body composition monitors; physical exercise apparatus for medical purposes; tomographs for medical purpos...

Filing Date

2025-05-08

View original document →

Classification

Agency
USPTO
Published
March 20th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM79433668

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Trademark Registration Research and Development Scientific Testing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Biotechnology

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Trademarks - Medical Services (Class 044) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.